CompletedEarly Phase 1

Effect of Allium Cepa in the Management of Shoulder Pain Post Stroke

Nigeria60 participantsStarted 2018-06-11

Plain-language summary

One of the disabling consequences of stroke is hemipleic shoulder pain. Hemiplegic shoulder pain could be most important hinderance to upper extremity function after stroke . Evidence for rehabilitation approaches for shuolder pain suggested diverse approaches with strong need for further studies. This study planned to investigate the effect of Allium Cepa in the management of shoulder pain post stroke using four arms of the studying with three intervention groups and control group All participants who met study inclusion criteria and gave their consent shall be assessed at baseline for impairment (Fugl Meyer Assessment), activity limitation (Brief Pain Inventory) and participation restrictions (Stroke Impact Scale)

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Stroke survivors with significant cognitive impairment (\< 18 on a mini mental scale) and language impairment that would prevent the patient from answering questions reliably.
✕. Stroke survivors who had sustained shoulder pain caused by condition other than hemiplegia such as fracture, vertebral origin, dislocation, inflammatory arthritis (rheumatoid and gout) and fibromyalgia.
✕. Participants who exhibit allergy to Allium Cepa (skin sensitivity or finds the odor offensive).
✕. Participants who do not agree to use Allium Cepa

What they're measuring

Visual Analogue Scale

Timeframe: 1 minute

Fugl Meyer Assessment Scale (upper extremity)

Timeframe: 15 minutes

Trial details

NCT IDNCT03468049

SponsorBayero University Kano, Nigeria

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-06-14

View on ClinicalTrials.gov More Stroke trials